The Effects of Ellagic Acid upon Brain Cells: A Mechanistic View and Future Directions

Neurochemical Research

Volumn 41, Issue 6, 2016, Pages 1219-1228

  de Oliveira, Marcos Roberto ^a  

^a FEDERAL UNIVERSITY OF MATO GROSSO   (Brazil)

Author keywords

Antioxidant; Brain; Ellagic acid; Glia; Neuron

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ALPHA SYNUCLEIN; ALPHA TOCOPHEROL SUCCINATE; AMYLOID BETA PROTEIN[1-42]; ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE 1; BENZYLOXYCARBONYLLEUCYLGLUTAMYLHISTIDYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CASPASE 9; CATALASE; CYTOCHROME C; CYTOCHROME P450; ELLAGIC ACID; HEAT SHOCK PROTEIN 70; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; NEUROPROTECTIVE AGENT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; POMEGRANATE EXTRACT; PROTEIN DISULFIDE ISOMERASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; RETINOIC ACID; SUPEROXIDE; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NRF2; UNINDEXED DRUG;

APOPTOSIS; ASTROCYTE; BRAIN CELL; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL SURVIVAL; CELL VIABILITY; DIFFUSE LEWY BODY DISEASE; DOWN REGULATION; ENDOPLASMIC RETICULUM STRESS; ENZYME RELEASE; GLIA CELL; GLIOMA CELL LINE; HUMAN; LIPID PEROXIDATION; MELANOMA CELL LINE; NEUROBLASTOMA CELL LINE; NEUROPROTECTION; NEUROTOXICITY; NITROSYLATION; NONHUMAN; ORAL CANCER CELL LINE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTATE CANCER CELL LINE; PROTEIN AGGREGATION; REVIEW; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; UPREGULATION; ANIMAL; BRAIN; BRAIN NEOPLASMS; CYTOLOGY; DRUG EFFECTS; FORECASTING; NERVE CELL; PATHOLOGY; TREATMENT OUTCOME;

ANIMALS; ANTIOXIDANTS; BRAIN; BRAIN NEOPLASMS; ELLAGIC ACID; FORECASTING; HUMANS; NEURONS; NEUROPROTECTIVE AGENTS; TREATMENT OUTCOME;

EID: 84957574816     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-016-1853-9     Document Type: Review

References (109)

1. Priyadarsini KI, Khopde SM, Kumar SS, Mohan H (2002) Free radical studies of ellagic acid, a natural phenolic antioxidant. J Agric Food Chem 50:2200–2206
2. Hwang JM, Cho JS, Kim TH, Lee YI (2010) Ellagic acid protects hepatocytes from damage by inhibiting mitochondrial production of reactive oxygen species. Biomed Pharmacother 64:264–270
3. García-Niño WR, Zazueta C (2015) Ellagic acid: pharmacological activities and molecular mechanisms involved in liver protection. Pharmacol Res 97:84–103
4. Lee JH, Won JH, Choi JM, Cha HH, Jang YJ, Park S, Kim HG, Kim HC, Kim DK (2014) Protective effect of ellagic acid on concanavalin A-induced hepatitis via toll-like receptor and mitogen-activated protein kinase/nuclear factor κB signaling pathways. J Agric Food Chem 62:10110–10117
5. Vieira O, Escargueil-Blanc I, Meilhac O, Basile JP, Laranjinha J, Almeida L, Salvayre R, Nègre-Salvayre A (1998) Effect of dietary phenolic compounds on apoptosis of human cultured endothelial cells induced by oxidized LDL. Br J Pharmacol 123:565–573
6. Yu YM, Wang ZH, Liu CH, Chen CS (2007) Ellagic acid inhibits IL-1beta-induced cell adhesion molecule expression in human umbilical vein endothelial cells. Br J Nutr 97:692–698
7. Papoutsi Z, Kassi E, Chinou I, Halabalaki M, Skaltsounis LA, Moutsatsou P (2008) Walnut extract (Juglans regia L.) and its component ellagic acid exhibit anti-inflammatory activity in human aorta endothelial cells and osteoblastic activity in the cell line KS483. Br J Nutr 99:715–722
8. Lee WJ, Ou HC, Hsu WC, Chou MM, Tseng JJ, Hsu SL, Tsai KL, Sheu WH (2010) Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells. J Vasc Surg 52:1290–1300
9. Ou HC, Lee WJ, Lee SD, Huang CY, Chiu TH, Tsai KL, Hsu WC, Sheu WH (2010) Ellagic acid protects endothelial cells from oxidized low-density lipoprotein-induced apoptosis by modulating the PI3K/Akt/eNOS pathway. Toxicol Appl Pharmacol 248:134–143
10. Khanduja KL, Avti PK, Kumar S, Mittal N, Sohi KK, Pathak CM (2006) Anti-apoptotic activity of caffeic acid, ellagic acid and ferulic acid in normal human peripheral blood mononuclear cells: a Bcl-2 independent mechanism. Biochim Biophys Acta 1760:283–289
11. El-Garhy AM, Abd El-Raouf OM, El-Sayeh BM, Fawzy HM, Abdallah DM (2014) Ellagic acid antiinflammatory and antiapoptotic potential mediate renoprotection in cisplatin nephrotoxic rats. J Biochem Mol Toxicol 28:472–479
12. Vijaya Padma V, Kalai Selvi P, Sravani S (2014) Protective effect of ellagic acid against TCDD-induced renal oxidative stress: modulation of CYP1A1 activity and antioxidant defense mechanisms. Mol Biol Rep 41:4223–4232
13. Saba KS, Parvez S, Chaudhari B, Ahmad F, Anjum S, Raisuddin S (2013) Ellagic acid attenuates bleomycin and cyclophosphamide-induced pulmonary toxicity in Wistar rats. Food Chem Toxicol 58:210–219
14. Gauliard B, Grieve D, Wilson R, Crozier A, Jenkins C, Mullen WD, Lean M (2008) The effects of dietary phenolic compounds on cytokine and antioxidant production by A549 cells. J Med Food 11:382–384
15. Goodwin EC, Atwood WJ, DiMaio D (2009) High-throughput cell-based screen for chemicals that inhibit infection by simian virus 40 and human polyomaviruses. J Virol 83:5630–5639
16. Nohynek LJ, Alakomi HL, Kähkönen MP, Heinonen M, Helander IM, Oksman-Caldentey KM, Puupponen-Pimiä RH (2006) Berry phenolics: antimicrobial properties and mechanisms of action against severe human pathogens. Nutr Cancer 54:18–32
17. Alfredsson CF, Rendel F, Liang QL, Sundström BE, Nånberg E (2015) Altered sensitivity to ellagic acid in neuroblastoma cells undergoing differentiation with 12-O-tetradecanoylphorbol-13-acetate and all-trans retinoic acid. Biomed Pharmacother 76:39–45
18. González-Sarrías A, Núñez-Sánchez MÁ, Tomé-Carneiro J, Tomás-Barberán FA, García-Conesa MT, Espín JC (2015) Comprehensive characterization of the effects of ellagic acid and urolithins on colorectal cancer and key associated molecular hallmarks: microRNA-cell specific induction of CDKN1A (p21) as a common mechanism involved. Mol Nutr Food Res. doi:10.1002/mnfr.201500780
19. Salimi A, Roudkenar MH, Sadeghi L, Mohseni A, Seydi E, Pirahmadi N, Pourahmad J (2015) Ellagic acid, a polyphenolic compound, selectively induces ROS-mediated apoptosis in cancerous B-lymphocytes of CLL patients by directly targeting mitochondria. Redox Biol 6:461–471
20. Mishra S, Vinayak M (2014) Ellagic acid induces novel and atypical PKC isoforms and promotes caspase-3 dependent apoptosis by blocking energy metabolism. Nutr Cancer 66:675–681
21. Takagi A, Sai K, Umemura T, Hasegawa R, Kurokawa Y (1995) Inhibitory effects of vitamin E and ellagic acid on 8-hydroxydeoxyguanosine formation in liver nuclear DNA of rats treated with 2-nitropropane. Cancer Lett 91:139–144
22. Wood AW, Huang MT, Chang RL, Newmark HL, Lehr RE, Yagi H, Sayer JM, Jerina DM, Conney AH (1982) Inhibition of the mutagenicity of bay-region diol epoxides of polycyclic aromatic hydrocarbons by naturally occurring plant phenols: exceptional activity of ellagic acid. Proc Natl Acad Sci USA 79:5513–5517
23. Mandal S, Ahuja A, Shivapurkar NM, Cheng SJ, Groopman JD, Stoner GD (1987) Inhibition of aflatoxin B1 mutagenesis in Salmonella typhimurium and DNA damage in cultured rat and human tracheobronchial tissues by ellagic acid. Carcinogenesis 8:1651–1656
24. Smith WA, Freeman JW, Gupta RC (2001) Effect of chemopreventive agents on DNA adduction induced by the potent mammary carcinogen dibenzo[a, l]pyrene in the human breast cells MCF-7. Mutat Res 480–481:97–108
25. Khanduja KL, Gandhi RK, Pathania V, Syal N (1999) Prevention of N-nitrosodiethylamine-induced lung tumorigenesis by ellagic acid and quercetin in mice. Food Chem Toxicol 37:313–318
26. Miller C, Castonguay A, Teel RW (1996) Modulation of the mutagenicity and metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by phenolic compounds. Mutat Res 368:221–233
27. Zahin M, Ahmad I, Gupta RC, Aqil F (2014) Punicalagin and ellagic acid demonstrate antimutagenic activity and inhibition of benzo[a]pyrene induced DNA adducts. Biomed Res Int 2014:467465
28. Grossi MR, Berni A, Pepe G, Filippi S, Meschini R, Papeschi C, Natarajan AT, Palitti F (2014) Evaluation of the effects of ellagic acid (EA) on 7,12-dimethylbenz(α) anthracene (DMBA) induced micronuclei in mammalian cells in vitro and in vivo. Toxicol Lett 224:240–245
29. Seeram NP, Lee R, Heber D (2004) Bioavailability of ellagic acid in human plasma after consumption of ellagitannins from pomegranate (Punica granatum L.) juice. Clin Chim Acta 348:63–68
30. Seeram NP, Henning SM, Zhang Y, Suchard M, Li Z, Heber D (2006) Pomegranate juice ellagitannin metabolites are present in human plasma and some persist in urine for up to 48 hours. J Nutr 136:2481–2485
31. Mertens-Talcott SU, Jilma-Stohlawetz P, Rios J, Hingorani L, Derendorf H (2006) Absorption, metabolism, and antioxidant effects of pomegranate (Punica granatum l.) polyphenols after ingestion of a standardized extract in healthy human volunteers. J Agric Food Chem 54:8956–8961
32. Cerdá B, Cerón JJ, Tomás-Barberán FA, Espín JC (2003) Repeated oral administration of high doses of the pomegranate ellagitannin punicalagin to rats for 37 days is not toxic. J Agric Food Chem 51:3493–3501
33. Lei F, Xing DM, Xiang L, Zhao YN, Wang W, Zhang LJ, Du LJ (2003) Pharmacokinetic study of ellagic acid in rat after oral administration of pomegranate leaf extract. J Chromatogr B Analyt Technol Biomed Life Sci 796:189–194
34. Yan L, Yin P, Ma C, Liu Y (2014) Method development and validation for pharmacokinetic and tissue distributions of ellagic acid using ultrahigh performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Molecules 19:18923–18935
35. Yang CS, Tzou BC, Liu YP, Tsai MJ, Shyue SK, Tzeng SF (2008) Inhibition of cadmium-induced oxidative injury in rat primary astrocytes by the addition of antioxidants and the reduction of intracellular calcium. J Cell Biochem 103:825–834
36. Waalkes MP (2000) Cadmium carcinogenesis in review. J Inorg Biochem 79:241–244
37. Ahmed S, Rahman A, Saleem M, Athar M, Sultana S (1999) Ellagic acid ameliorates nickel induced biochemical alterations: diminution of oxidative stress. Hum Exp Toxicol 18:691–698
38. Rojanathammanee L, Puig KL, Combs CK (2013) Pomegranate polyphenols and extract inhibit nuclear factor of activated T-cell activity and microglial activation in vitro and in a transgenic mouse model of Alzheimer disease. J Nutr 143:597–605
39. Ahad A, Ganai AA, Mujeeb M, Siddiqui WA (2014) Ellagic acid, an NF-κB inhibitor, ameliorates renal function in experimental diabetic nephropathy. Chem Biol Interact 219:64–75
40. Zhou E, Fu Y, Wei Z, Yang Z (2014) Inhibition of allergic airway inflammation through the blockage of NF-κB activation by ellagic acid in an ovalbumin-induced mouse asthma model. Food Funct 5:2106–2112
41. Anitha P, Priyadarsini RV, Kavitha K, Thiyagarajan P, Nagini S (2013) Ellagic acid coordinately attenuates Wnt/β-catenin and NF-κB signaling pathways to induce intrinsic apoptosis in an animal model of oral oncogenesis. Eur J Nutr 52:75–84
42. Rosillo MA, Sánchez-Hidalgo M, Cárdeno A, Aparicio-Soto M, Sánchez-Fidalgo S, Villegas I, de la Lastra CA (2012) Dietary supplementation of an ellagic acid-enriched pomegranate extract attenuates chronic colonic inflammation in rats. Pharmacol Res 66:235–242
43. Mattson MP, Goodman Y, Luo H, Fu W, Furukawa K (1997) Activation of NF-kappaB protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. J Neurosci Res 49:681–697
44. Salminen A, Hyttinen JM, Kaarniranta K (2011) AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespan. J Mol Med (Berl) 89:667–676
45. Xu Y, Kiningham KK, Devalaraja MN, Yeh CC, Majima H, Kasarskis EJ, St Clair DK (1999) An intronic NF-kappaB element is essential for induction of the human manganese superoxide dismutase gene by tumor necrosis factor-alpha and interleukin-1beta. DNA Cell Biol 18:709–722
46. Sompol P, Xu Y, Ittarat W, Daosukho C, St Clair D (2006) NF-kappaB-associated MnSOD induction protects against beta-amyloid-induced neuronal apoptosis. J Mol Neurosci 29:279–288
47. Yamamoto Y, Gaynor RB (2001) Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest 107:135–142
48. Lopes FM, Schröder R, da Frota ML, Zanotto-Filho A Jr, Müller CB, Pires AS, Meurer RT, Colpo GD, Gelain DP, Kapczinski F, Moreira JC, da Fernandes MC, Klamt F (2010) Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies. Brain Res 1337:85–94
49. Xie HR, Hu LS, Li GY (2010) SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson’s disease. Chin Med J (Engl) 123:1086–1092
50. Schneider L, Giordano S, Zelickson BR, Johnson M, Benavides G, Ouyang X, Fineberg N, Darley-Usmar VM, Zhang J (2011) Differentiation of SH-SY5Y cells to a neuronal phenotype changes cellular bioenergetics and the response to oxidative stress. Free Radic Biol Med 51:2007–2017
51. Feng Y, Yang SG, Du XT, Zhang X, Sun XX, Zhao M, Sun GY, Liu RT (2009) Ellagic acid promotes Abeta42 fibrillization and inhibits Abeta42-induced neurotoxicity. Biochem Biophys Res Commun 390:1250–1254
52. Kong J, Ren G, Jia N, Wang Y, Zhang H, Zhang W, Chen B, Cao Y (2013) Effects of nicorandil in neuroprotective activation of PI3K/AKT pathways in a cellular model of Alzheimer’s disease. Eur Neurol 70:233–241
53. Kwon SH, Ma SX, Hwang JY, Lee SY, Jang CG (2015) Involvement of the Nrf2/HO-1 signaling pathway in sulfuretin-induced protection against amyloid beta 25–35 neurotoxicity. Neuroscience 304:14–28
54. Li Y, Dai YB, Sun JY, Xiang Y, Yang J, Dai SY, Zhang X (2015) Neuroglobin attenuates beta amyloid-induced apoptosis through inhibiting caspases activity by activating PI3K/Akt signaling pathway. J Mol Neurosci. doi:10.1007/s12031-015-0645-z
55. Kabiraj P, Marin JE, Varela-Ramirez A, Zubia E, Narayan M (2014) Ellagic acid mitigates SNO-PDI induced aggregation of Parkinsonian biomarkers. ACS Chem Neurosci 5:1209–1220
56. Oberdoerster J, Rabin RA (1999) NGF-differentiated and undifferentiated PC12 cells vary in induction of apoptosis by ethanol. Life Sci 64:PL267–PL272
57. Hayakawa N, Shiozaki M, Shibata M, Koike M, Uchiyama Y, Matsuura N, Gotow T (2013) Resveratrol affects undifferentiated and differentiated PC12 cells differently, particularly with respect to possible differences in mitochondrial and autophagic functions. Eur J Cell Biol 92:30–43
58. Pera M, Camps P, Muñoz-Torrero D, Perez B, Badia A, Clos Guillen MV (2013) Undifferentiated and differentiated PC12 cells protected by huprines against injury induced by hydrogen peroxide. PLoS One 8:e74344
59. Tabopda TK, Ngoupayo J, Liu JW, Mitaine-Offer AC, Ngadjui BT, Lacaille-Dubois MA, Luu B (2009) Induction of neuronal differentiation in neurosphere stem cells by ellagic acid derivatives. Nat Prod Commun 4:517–520
60. Fjaeraa C, Nånberg E (2009) Effect of ellagic acid on proliferation, cell adhesion and apoptosis in SH-SY5Y human neuroblastoma cells. Biomed Pharmacother 63:254–261
61. Seidenfaden R, Hildebrandt H (2001) Retinoic acid-induced changes in polysialyltransferase mRNA expression and NCAM polysialylation in human neuroblastoma cells. J Neurobiol 46:11–28
62. Linnala A, Lehto VP, Virtanen I (1997) Neuronal differentiation in SH-SY5Y human neuroblastoma cells induces synthesis and secretion of tenascin and upregulation of alpha(v) integrin receptors. J Neurosci Res 49:53–63
63. Lasorella A, Iavarone A, Israel MA (1995) Differentiation of neuroblastoma enhances Bcl-2 expression and induces alterations of apoptosis and drug resistance. Cancer Res 55:4711–4716
64. Tieu K, Zuo DM, Yu PH (1999) Differential effects of staurosporine and retinoic acid on the vulnerability of the SH-SY5Y neuroblastoma cells: involvement of bcl-2 and p53 proteins. J Neurosci Res 58:426–435
65. Alfredsson CF, Ding M, Liang QL, Sundström BE, Nånberg E (2014) Ellagic acid induces a dose- and time-dependent depolarization of mitochondria and activation of caspase-9 and -3 in human neuroblastoma cells. Biomed Pharmacother 68:129–135
66. Hagiwara Y, Kasukabe T, Kaneko Y, Niitsu N, Okabe-Kado J (2010) Ellagic acid, a natural polyphenolic compound, induces apoptosis and potentiates retinoic acid-induced differentiation of human leukemia HL-60 cells. Int J Hematol 92:136–143
67. Malik A, Afaq S, Shahid M, Akhtar K, Assiri A (2011) Influence of ellagic acid on prostate cancer cell proliferation: a caspase-dependent pathway. Asian Pac J Trop Med 4:550–555
68. Green DR, Galluzzi L, Kroemer G (2014) Metabolic control of cell death. Science 345:1250256
69. Mathur A, Vallano ML (2000) 2,2′,3,3′,4,4′-Hexahydroxy-1,1′-biphenyl-6,6′-dimethanol dimethyl ether (HBDDE)-induced neuronal apoptosis independent of classical protein kinase C alpha or gamma inhibition. Biochem Pharmacol 60:809–815
70. Kim S, Nishimoto SK, Bumgardner JD, Haggard WO, Gaber MW, Yang Y (2010) A chitosan/beta-glycerophosphate thermo-sensitive gel for the delivery of ellagic acid for the treatment of brain cancer. Biomaterials 31:4157–4166
71. Le Tien C, Lacroix M, Ispas-Szabo P, Mateescu MA (2003) N-acylated chitosan: hydrophobic matrices for controlled drug release. J Control Release 93:1–13
72. Kim S, Gaber MW, Zawaski JA, Zhang F, Richardson M, Zhang XA, Yang Y (2009) The inhibition of glioma growth in vitro and in vivo by a chitosan/ellagic acid composite biomaterial. Biomaterials 30:4743–4751
73. Arulmozhi V, Pandian K, Mirunalini S (2013) Ellagic acid encapsulated chitosan nanoparticles for drug delivery system in human oral cancer cell line (KB). Colloids Surf B Biointerfaces 110:313–320
74. Kim S, Liu Y, Gaber MW, Bumgardner JD, Haggard WO, Yang Y (2009) Development of chitosan-ellagic acid films as a local drug delivery system to induce apoptotic death of human melanoma cells. J Biomed Mater Res B Appl Biomater 90:145–155
75. Hassoun EA, Vodhanel J, Abushaban A (2004) The modulatory effects of ellagic acid and vitamin E succinate on TCDD-induced oxidative stress in different brain regions of rats after subchronic exposure. J Biochem Mol Toxicol 18:196–203
76. Henshel DS, Martin JW, Norstrom R, Whitehead P, Steeves JD, Cheng KM (1995) Morphometric abnormalities in brains of great blue heron hatchlings exposed in the wild to PCDDs. Environ Health Perspect 103(Suppl 4):61–66
77. Neuberger M, Kundi M, Jäger R (1998) Chloracne and morbidity after dioxin exposure (preliminary results). Toxicol Lett 96–97:347–350
78. Klawans HL (1987) Dystonia and tremor following exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mov Disord 2:255–261
79. Brouwer A, Ahlborg UG, Van den Berg M, Birnbaum LS, Boersma ER, Bosveld B, Denison MS, Gray LE, Hagmar L, Holene E et al (1995) Functional aspects of developmental toxicity of polyhalogenated aromatic hydrocarbons in experimental animals and human infants. Eur J Pharmacol 293:1–40
80. Bondy SC, Naderi S (1994) Contribution of hepatic cytochrome P450 systems to the generation of reactive oxygen species. Biochem Pharmacol 48:155–159
81. Hrycay EG, Bandiera SM (2015) Involvement of cytochrome P450 in reactive oxygen species formation and cancer. Adv Pharmacol 74:35–84
82. Uzar E, Alp H, Cevik MU, Fırat U, Evliyaoglu O, Tufek A, Altun Y (2012) Ellagic acid attenuates oxidative stress on brain and sciatic nerve and improves histopathology of brain in streptozotocin-induced diabetic rats. Neurol Sci 33:567–574
83. Litvinov D, Mahini H, Garelnabi M (2012) Antioxidant and anti-inflammatory role of paraoxonase 1: implication in arteriosclerosis diseases. N Am J Med Sci 4:523–532
84. Boesch-Saadatmandi C, Rimbach G, Schrader C, Kofler BM, Armah CK, Minihane AM (2010) Determinants of paraoxonase activity in healthy adults. Mol Nutr Food Res 54:1842–1850
85. Farbood Y, Sarkaki A, Dianat M, Khodadadi A, Haddad MK, Mashhadizadeh S (2015) Ellagic acid prevents cognitive and hippocampal long-term potentiation deficits and brain inflammation in rat with traumatic brain injury. Life Sci 124:120–127
86. Cunningham AJ, Murray CA, O’Neill LA, Lynch MA, O’Connor JJ (1996) Interleukin-1 beta (IL-1 beta) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neurosci Lett 203:17–20
87. Ross FM, Allan SM, Rothwell NJ, Verkhratsky A (2003) A dual role for interleukin-1 in LTP in mouse hippocampal slices. J Neuroimmunol 144:61–67
88. Vereker E, Campbell V, Roche E, McEntee E, Lynch MA (2000) Lipopolysaccharide inhibits long term potentiation in the rat dentate gyrus by activating caspase-1. J Biol Chem 275:26252–26258
89. Ban E, Milon G, Prudhomme N, Fillion G, Haour F (1991) Receptors for interleukin-1 (alpha and beta) in mouse brain: mapping and neuronal localization in hippocampus. Neuroscience 43:21–30
90. Parnet P, Amindari S, Wu C, Brunke-Reese D, Goujon E, Weyhenmeyer JA, Dantzer R, Kelley KW (1994) Expression of type I and type II interleukin-1 receptors in mouse brain. Brain Res Mol Brain Res 27:63–70
91. Rothwell NJ, Hopkins SJ (1995) Cytokines and the nervous system II: actions and mechanisms of action. Trends Neurosci 18:130–136
92. Goshen I, Kreisel T, Ounallah-Saad H, Renbaum P, Zalzstein Y, Ben-Hur T, Levy-Lahad E, Yirmiya R (2007) A dual role for interleukin-1 in hippocampal-dependent memory processes. Psychoneuroendocrinology 32:1106–1115
93. Viviani B, Bartesaghi S, Gardoni F, Vezzani A, Behrens MM, Bartfai T, Binaglia M, Corsini E, Di Luca M, Galli CL, Marinovich M (2003) Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci 23:8692–8700
94. Pang X, Li T, Feng L, Zhao J, Zhang X, Liu J (2014) Ellagic acid-induced thrombotic focal cerebral ischemic model in rats. J Pharmacol Toxicol Methods 69:217–222
95. Seeram NP, Zhang Y, McKeever R, Henning SM, Lee RP, Suchard MA, Li Z, Chen S, Thames G, Zerlin A, Nguyen M, Wang D, Dreher M, Heber D (2008) Pomegranate juice and extracts provide similar levels of plasma and urinary ellagitannin metabolites in human subjects. J Med Food 11:390–394
96. Banihani S, Swedan S, Alguraan Z (2013) Pomegranate and type 2 diabetes. Nutr Res 33:341–348
97. Vlachojannis C, Zimmermann BF, Chrubasik-Hausmann S (2015) Efficacy and safety of pomegranate medicinal products for cancer. Evid Based Complement Alternat Med 2015:258598
98. Ramos S (2008) Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways. Mol Nutr Food Res 52:507–526
99. Mercurio F, Manning AM (1999) NF-kappaB as a primary regulator of the stress response. Oncogene 18:6163–6171
100. Loren DJ, Seeram NP, Schulman RN, Holtzman DM (2005) Maternal dietary supplementation with pomegranate juice is neuroprotective in an animal model of neonatal hypoxic-ischemic brain injury. Pediatr Res 57:858–864
101. Celik I, Temur A, Isik I (2009) Hepatoprotective role and antioxidant capacity of pomegranate (Punica granatum) flowers infusion against trichloroacetic acid-exposed in rats. Food Chem Toxicol 47:145–149
102. Bookheimer SY, Renner BA, Ekstrom A, Li Z, Henning SM, Brown JA, Jones M, Moody T, Small GW (2013) Pomegranate juice augments memory and FMRI activity in middle-aged and older adults with mild memory complaints. Evid Based Complement Alternat Med 2013:946298
103. Hajipour S, Sarkaki A, Mohammad S, Mansouri T, Pilevarian A, RafieiRad M (2014) Motor and cognitive deficits due to permanent cerebral hypoperfusion/ischemia improve by pomegranate seed extract in rats. Pak J Biol Sci 17:991–998
104. Essa MM, Subash S, Akbar M, Al-Adawi S, Guillemin GJ (2015) Long-term dietary supplementation of pomegranates, figs and dates alleviate neuroinflammation in a transgenic mouse model of Alzheimer’s disease. PLoS One 10:e0120964
105. Subash S, Essa MM, Al-Asmi A, Al-Adawi S, Vaishnav R, Braidy N, Manivasagam T, Guillemin GJ (2014) Pomegranate from Oman alleviates the brain oxidative damage in transgenic mouse model of Alzheimer’s disease. J Tradit Complement Med 4:232–238
106. Subash S, Braidy N, Essa MM, Zayana AB, Ragini V, Al-Adawi S, Al-Asmi A, Guillemin GJ (2015) Long-term (15 mo) dietary supplementation with pomegranates from Oman attenuates cognitive and behavioral deficits in a transgenic mice model of Alzheimer’s disease. Nutrition 31:223–229
107. Braidy N, Selvaraju S, Essa MM, Vaishnav R, Al-Adawi S, Al-Asmi A, Al-Senawi H, Abd Alrahman Alobaidy A, Lakhtakia R, Guillemin GJ (2013) Neuroprotective effects of a variety of pomegranate juice extracts against MPTP-induced cytotoxicity and oxidative stress in human primary neurons. Oxid Med Cell Longev 2013:685909
108. Ahmed MA, El Morsy EM, Ahmed AA (2014) Pomegranate extract protects against cerebral ischemia/reperfusion injury and preserves brain DNA integrity in rats. Life Sci 110:61–69
109. Pirinççioğlu M, Kızıl G, Kızıl M, Kanay Z, Ketani A (2014) The protective role of pomegranate juice against carbon tetrachloride-induced oxidative stress in rats. Toxicol Ind Health 30:910–918